Bitget App
Trade smarter
US-listed company LIXTE Biotechnology launches crypto reserve strategy, plans to allocate 25% of funds to BTC
Show original
According to ChainCatcher, Nasdaq-listed company LIXTE Biotechnology has announced that its board of directors has approved a strategic capital allocation plan to acquire cryptocurrencies as part of the company’s funds. The board has also approved allocating 25% of its funds to cryptocurrencies, including Bitcoin and potentially other digital assets as appropriate.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Creditlink ($CDL) raises over 17 million USD1 and 23,800 FORM within just 5 minutes of launch
Chaincatcher•2025/08/28 08:16
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$113,291.05
+2.43%
Ethereum
ETH
$4,602.94
+0.46%
XRP
XRP
$3
-0.14%
Tether USDt
USDT
$1
+0.14%
BNB
BNB
$870.66
+1.76%
Solana
SOL
$213.86
+5.50%
USDC
USDC
$1
+0.10%
Dogecoin
DOGE
$0.2242
+2.65%
TRON
TRX
$0.3496
+0.25%
Cardano
ADA
$0.8716
+1.65%
How to sell PI
Bitget lists PI – Buy or sell PI quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now